ACRV
Acrivon Therapeutics, Inc. Common Stock
NASDAQ: ACRV · HEALTHCARE · BIOTECHNOLOGY
$1.81
-4.74% today
Updated 2026-04-29
Market cap
$70.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.02
Dividend yield
—
52W range
$1 – $4
Volume
0.9M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$11.50
+535.36%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-15.46M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-29.68M | $-60.39M | $-80.56M | $-77.91M | $-18.98M |
| EPS | — | — | — | — | $-2.02 |
| Free cash flow | $-32.28M | $-43.93M | $-68.44M | $-65.33M | $-15.46M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Acrivon Therapeutics, Inc. Common Stock trades at $1.81. Our Smart Value Score of 30/100 indicates the stock is weak.
Frequently asked questions
What is Acrivon Therapeutics, Inc. Common Stock's stock price?
Acrivon Therapeutics, Inc. Common Stock (ACRV) trades at $1.81.
Is Acrivon Therapeutics, Inc. Common Stock overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell).
What is the price target of Acrivon Therapeutics, Inc. Common Stock (ACRV)?
The analyst target price is $11.50, representing +535.4% upside from the current price of $1.81.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-53.90%
Beta1.74
50D MA$1.63
200D MA$1.79
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—